S Shu Selected Research

S Shu Research Topics

Disease

15	Neoplasms (Cancer) 12/2001 - 01/2000
5	Neoplasm Metastasis (Metastasis) 07/2011 - 10/2000
2	Fever (Fevers) 10/2012 - 06/2000
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 09/2009 - 08/2007
2	Infections 08/2007 - 08/2000
2	Fibrosarcoma 01/2004 - 04/2001
2	Carcinoma (Carcinomatosis) 04/2001 - 10/2000
2	Glioma (Gliomas) 03/2001 - 06/2000
1	Cleft Lip (Harelip) 11/2019
1	Cleft Palate (Palate, Cleft) 11/2019
1	Lymphatic Metastasis 07/2013
1	Ovarian Neoplasms (Ovarian Cancer) 07/2013
1	Cholangitis 10/2011
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 10/2011
1	Breast Neoplasms (Breast Cancer) 07/2011
1	Humoral Hypercalcemia Of Malignancy 08/2007
1	Experimental Melanoma 01/2004
1	Melanoma (Melanoma, Malignant) 01/2004
1	Sarcoma (Soft Tissue Sarcoma) 03/2001
1	Pain (Aches) 02/2001
1	Sickle Cell Anemia (Hemoglobin S Disease) 02/2001
1	Brain Neoplasms (Brain Tumor) 01/2001
1	Squamous Cell Carcinoma of Head and Neck 10/2000
1	Nausea 06/2000
1	Brain Injuries (Brain Injury) 01/2000

Drug/Important Bio-Agent (IBA)

6	Interleukin-2 (IL2)IBA 12/2001 - 10/2000
5	CytokinesIBA 10/2011 - 01/2000
5	L-SelectinIBA 12/2001 - 10/2000
4	VaccinesIBA 01/2004 - 10/2000
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2004 - 06/2000
3	AntigensIBA 10/2011 - 01/2001
3	Neoplasm Antigens (Tumor Antigens)IBA 04/2001 - 01/2000
2	Monoclonal AntibodiesIBA 12/2001 - 10/2000
2	Therapeutic UsesIBA 12/2001 - 03/2001
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 11/2019
1	PlatinumIBA 07/2013
1	Blood Proteins (Serum Proteins)IBA 10/2012
1	ProteomeIBA 10/2012
1	AutoantibodiesIBA 10/2011
1	AutoantigensIBA 10/2011
1	2-octynoic acidIBA 10/2011
1	Poly I-CIBA 10/2011
1	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 10/2011
1	ChromatinIBA 07/2011
1	Phosphotransferases (Kinase)IBA 07/2011
1	Matrix Metalloproteinases (MMPs)IBA 09/2009
1	Parathyroid Hormone-Related ProteinIBA 08/2007
1	Protein SIBA 08/2007
1	NF-kappa B (NF-kB)IBA 08/2007
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2004
1	HLA-DR7 Antigen (HLA DR7 Antigen)IBA 01/2004
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 01/2004
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2004
1	MethylcholanthreneIBA 12/2001
1	Indicators and Reagents (Reagents)IBA 12/2001
1	anti-LFA-1 monoclonal antibody (Odulimomab)IBA 04/2001
1	Cell Adhesion MoleculesIBA 04/2001
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 04/2001
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2001
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 04/2001
1	Integrin alpha4beta1 (VLA-4)IBA 04/2001
1	AntibodiesIBA 03/2001
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2001
1	PerforinIBA 12/2000
1	LigandsIBA 12/2000
1	Immunoglobulins (Immunoglobulin)IBA 10/2000
1	Proteins (Proteins, Gene)FDA Link 10/2000
1	Staphylococcal enterotoxin AIBA 10/2000
1	EcdysteroidsIBA 08/2000
1	Cancer VaccinesIBA 06/2000
1	Protons (Proton)IBA 01/2000
1	Histocompatibility Antigens Class IIIBA 01/2000

Therapy/Procedure

5	Therapeutics 02/2001 - 06/2000
4	Immunotherapy 03/2001 - 07/2000
2	Drug Therapy (Chemotherapy) 07/2013 - 01/2001
2	Ligation 12/2001 - 10/2000
1	Cytoreduction Surgical Procedures 07/2013
1	Life Support Care 01/2004
1	Radiotherapy 01/2001
1	Injections 10/2000